Arcturus Pharmaceutical
Executive Summary
Second round venture capital funding round of $5 mil. is completed, the Cambridge, Mass.-based dermatologic disorders R&D firm announces April 6.
Second round venture capital funding round of $5 mil. is completed,
the Cambridge, Mass.-based dermatologic disorders R&D firm
announces April 6. |